CRYO-CELL Posts All-Time Monthly Sales Record

[Wise Young]

Very interesting... this is the company that does umbilical cord processing and storage.

http://www.prnewswire.com/cgi-bin/st...1776738&EDATE=

CRYO-CELL Posts All-Time Monthly Sales Record
CRYO-CELL LOGO
Cryo-Cell logo. (PRNewsFoto)[AG]
CLEARWATER, FL USA 01/16/2001

CLEARWATER, Fla., Aug. 2 /PRNewswire-FirstCall/ --
CRYO-CELL International, Inc. (Nasdaq: CCEL) announced today that the Company
reached record monthly sales with unaudited July 2002 revenues of
approximately $638,000.
(Photo: http://www.newscom.com/cgi-bin/prnh/.../FLTU004LOGO-b )

Highlights for July 2002 include the following:

* Year-to-date 2002 revenues from umbilical cord blood processing and
preservation only were $4.5 million vs. $2.8 million during the first
eight months of 2001, representing a 62% year-over-year increase.
* Total YTD revenues were $4.5 million vs. $3.5 million in 2001,
representing a 28% increase. (2001 revenues included $750,000 from the
sale of a Revenue Sharing Agreement.)
* July 2002 revenues of $638,000 represent a 43% increase over comparable
July 2001 revenues of $446,926 from umbilical cord blood processing and
preservation.
* Year-to-date recurring storage revenue was $700,000 vs. $328,000 during
the same period of 2001, representing a 115% increase.

John V. Hargiss, President and Chief Executive Officer stated, "July 2002
was the largest revenue month in the Company's history, surpassing the prior
month's record performance by 6%. The record year-to-date revenue performance
has been driven, in part, by the last 4 months of record processing-related
revenues and a doubling of storage revenues for previously processed and
banked specimens. In addition, inquiries regarding our cord blood processing
service reached record levels of nearly 5,000 during July. Actual client
enrollments increased to over 1,900, a 5% increase over June levels." Hargiss
continued, "We attribute this growing demand to the Company's marketing and
referral programs that have created a robust referral base from physicians and
other medical caregivers. Moreover, CRYO-CELL's personalized and caring
service has created thousands of satisfied clients who in turn have become
repeat customers and a steady source of new client referrals."
According to the Company, none of the above figures include license fees
from international operations, which are included as other income. The
Company's cash position of over $5 million remains strong with no long-term
debt.
The Company reported that it had processed and preserved a record number
of cord blood specimens, with July units processed exceeding June by over 9%.
Total banked specimens have reached approximately 38,000 in the U.S.
CRYO-CELL is a publicly traded company. NASDAQ Symbol ... C C E L.
Based in Clearwater, Florida, CRYO-CELL is now the world's largest and fastest
growing U-Cord(TM) stem cell banking firm, offering affordable cord blood
storage exclusively for the benefit of newborn babies and possibly other
members of their family. CRYO-CELL has pioneered America's most affordable U-
Cord preservation program. Web site http://www.cryo-cell.com.

Forward-Looking Statement
Statements wherein the terms "believes," "intends," "projects" or
"expects" as used are intended to reflect "forward-looking statements" of the
Company. The information contained herein is subject to various risks,
uncertainties and other factors that could cause actual results to differ
materially from the results anticipated in such forward-looking statements or
paragraphs. Readers should carefully review the risk factors described in
other documents the Company files from time to time with the Securities and
Exchange Commission, including the most recent Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K filed by
the Company.